38 datasets found
  1. T

    Ghana - Prevalence Of HIV, Male (% Ages 15-24)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated May 29, 2017
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). Ghana - Prevalence Of HIV, Male (% Ages 15-24) [Dataset]. https://tradingeconomics.com/ghana/prevalence-of-hiv-male-percent-ages-15-24-wb-data.html
    Explore at:
    csv, excel, json, xmlAvailable download formats
    Dataset updated
    May 29, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    Ghana
    Description

    Prevalence of HIV, male (% ages 15-24) in Ghana was reported at 0.3 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Ghana - Prevalence of HIV, male (% ages 15-24) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

  2. Countries with the highest prevalence of HIV in 2000 and 2024

    • statista.com
    Updated Jul 14, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Countries with the highest prevalence of HIV in 2000 and 2024 [Dataset]. https://www.statista.com/statistics/270209/countries-with-the-highest-global-hiv-prevalence/
    Explore at:
    Dataset updated
    Jul 14, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    Worldwide
    Description

    Among all countries worldwide those in sub-Saharan Africa have the highest rates of HIV. The countries with the highest rates of HIV include Eswatini, South Africa, and Lesotho. In 2024, Eswatini had the highest prevalence of HIV with a rate of around ** percent. Other countries, such as Zimbabwe, have significantly decreased their HIV prevalence. Community-based HIV services are considered crucial to the prevention and treatment of HIV. HIV Worldwide The human immunodeficiency virus (HIV) is a viral infection that is transmitted via exposure to infected semen, blood, vaginal and anal fluids, and breast milk. HIV destroys the human immune system, rendering the host unable to fight off secondary infections. Globally, the number of people living with HIV has generally increased over the past two decades. However, the number of HIV-related deaths has decreased significantly in recent years. Despite being a serious illness that affects millions of people, medication exists that effectively manages the progression of the virus in the body. These medications are called antiretroviral drugs. HIV Treatment Generally, global access to antiretroviral treatment has increased. However, despite being available worldwide, not all adults have access to antiretroviral drugs. There are many different antiretroviral drugs available on the market. As of 2024, ********, an antiretroviral marketed by Gilead, was the leading HIV treatment based on revenue.

  3. HIV: annual data

    • gov.uk
    Updated Oct 1, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    UK Health Security Agency (2024). HIV: annual data [Dataset]. https://www.gov.uk/government/statistics/hiv-annual-data-tables
    Explore at:
    Dataset updated
    Oct 1, 2024
    Dataset provided by
    GOV.UKhttp://gov.uk/
    Authors
    UK Health Security Agency
    Description

    The following slide sets are available to download for presentational use:

    New HIV diagnoses, AIDS and deaths are collected from HIV outpatient clinics, laboratories and other healthcare settings. Data relating to people living with HIV is collected from HIV outpatient clinics. Data relates to England, Wales, Northern Ireland and Scotland, unless stated.

    HIV testing, pre-exposure prophylaxis, and post-exposure prophylaxis data relates to activity at sexual health services in England only.

    View the pre-release access lists for these statistics.

    Previous reports, data tables and slide sets are also available for:

    Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the https://code.statisticsauthority.gov.uk/" class="govuk-link">Code of Practice for Statistics that all producers of Official Statistics should adhere to.

    Additional information on HIV surveillance can be found in the HIV Action Plan for England monitoring and evaluation framework reports. Other HIV in the UK reports published by Public Health England (PHE) are available online.

  4. T

    Namibia - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Aug 10, 2013
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2013). Namibia - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/namibia/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    json, xml, excel, csvAvailable download formats
    Dataset updated
    Aug 10, 2013
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    Namibia
    Description

    Prevalence of HIV, total (% of population ages 15-49) in Namibia was reported at 11 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Namibia - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

  5. T

    Trinidad And Tobago - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 6, 2017
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). Trinidad And Tobago - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/trinidad-and-tobago/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    excel, csv, xml, jsonAvailable download formats
    Dataset updated
    Jun 6, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    Trinidad and Tobago
    Description

    Prevalence of HIV, total (% of population ages 15-49) in Trinidad and Tobago was reported at 1 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Trinidad and Tobago - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

  6. Total number of AIDS-related deaths worldwide 2000-2024

    • statista.com
    Updated Jul 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Total number of AIDS-related deaths worldwide 2000-2024 [Dataset]. https://www.statista.com/statistics/257209/number-of-aids-related-deaths-worldwide-since-2001/
    Explore at:
    Dataset updated
    Jul 15, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    Worldwide
    Description

    UNAIDS estimated that there were some ******* people worldwide that died from acquired immune deficiency syndrome (AIDS) in 2024. This statistic depicts the total number of annual AIDS-related deaths worldwide from 2000 to 2024. HIV/AIDS burden A majority of countries with the highest burden due to HIV and AIDS are in Africa- in 2024, the highest number of AIDS-related deaths occurred in South Africa and Mozambique and the highest prevalence of HIV was found in Eswatini. Although access to life-saving antiretroviral therapy treatment (ART) has increased globally over recent years, many individuals living with HIV still lack access to ART. Barriers and interventions In part due to the development of ART, the number of people living with HIV worldwide is continuing to increase, reaching almost ** million in 2024. Important public health measures to combat the burden of the disease include a combination of biomedical and behavioral interventions such as pre- and post-exposure prophylaxis, and context-specific structural interventions to reduce barriers to supplies and education. One prominent barrier faced by those living with HIV is stigma, which can often cause disadvantages in many areas of life, including employment, use of health services, and social support.

  7. Number of people with HIV in select countries in Africa 2023

    • statista.com
    • ai-chatbox.pro
    Updated Aug 21, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). Number of people with HIV in select countries in Africa 2023 [Dataset]. https://www.statista.com/statistics/1305217/number-people-with-hiv-african-countries/
    Explore at:
    Dataset updated
    Aug 21, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    2023
    Area covered
    Africa
    Description

    As of 2023, South Africa was the country with the highest number of people living with HIV in Africa. At that time, around 7.7 million people in South Africa were HIV positive. In Mozambique, the country with the second-highest number of HIV-positive people in Africa, around 2.4 million people were living with HIV. Which country in Africa has the highest prevalence of HIV? Although South Africa has the highest total number of people living with HIV in Africa, it does not have the highest prevalence of HIV on the continent. Eswatini currently has the highest prevalence of HIV in Africa and worldwide, with almost 26 percent of the population living with HIV. South Africa has the third-highest prevalence, with around 18 percent of the population HIV positive. Eswatini also has the highest rate of new HIV infections per 1,000 population worldwide, followed by Lesotho and South Africa. However, South Africa had the highest total number of new HIV infections in 2023, with around 150,000 people newly infected with HIV that year. Deaths from HIV in Africa Thanks to advances in treatment and awareness, HIV/AIDS no longer contributes to a significant amount of death in many countries. However, the disease is still the fourth leading cause of death in Africa, accounting for around 5.6 percent of all deaths. In 2023, South Africa and Nigeria were the countries with the highest number of AIDS-related deaths worldwide with 50,000 and 45,000 such deaths, respectively. Although not every country in the leading 25 for AIDS-related deaths is found in Africa, African countries account for the majority of countries on the list. Fortunately, HIV treatment has become more accessible in Africa over the years and now up to 95 percent of people living with HIV in Eswatini are receiving antiretroviral therapy (ART). Access to ART does vary from country to country, however, with around 77 percent of people who are HIV positive in South Africa receiving ART, and only 31 percent in the Congo.

  8. T

    France - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 1, 2017
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). France - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/france/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    csv, xml, json, excelAvailable download formats
    Dataset updated
    Jun 1, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    France
    Description

    Prevalence of HIV, total (% of population ages 15-49) in France was reported at 0.3 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. France - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

  9. T

    Hungary - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated May 30, 2017
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). Hungary - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/hungary/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    excel, xml, csv, jsonAvailable download formats
    Dataset updated
    May 30, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    Hungary
    Description

    Prevalence of HIV, total (% of population ages 15-49) in Hungary was reported at 0.1 % in 2018, according to the World Bank collection of development indicators, compiled from officially recognized sources. Hungary - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

  10. T

    Peru - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 4, 2017
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). Peru - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/peru/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    json, excel, csv, xmlAvailable download formats
    Dataset updated
    Jun 4, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    Peru
    Description

    Prevalence of HIV, total (% of population ages 15-49) in Peru was reported at 0.4 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Peru - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

  11. T

    Romania - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated May 30, 2017
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). Romania - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/romania/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    csv, json, excel, xmlAvailable download formats
    Dataset updated
    May 30, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    Romania
    Description

    Prevalence of HIV, total (% of population ages 15-49) in Romania was reported at 0.1 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Romania - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

  12. w

    Global Human Immunodeficiency Virus Hiv Market Research Report: By Treatment...

    • wiseguyreports.com
    Updated Sep 23, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Human Immunodeficiency Virus Hiv Market Research Report: By Treatment Options (Antiretroviral Therapy, Pre-exposure Prophylaxis (PrEP), Post-exposure Prophylaxis (PEP)), By Disease Stage (Acute HIV Infection, Chronic HIV Infection), By Patient Population (Adult HIV Patients, Pediatric HIV Patients), By Mode of Transmission (Sexual Contact, Intravenous Drug Use, Mother-to-Child Transmission), By Comorbidities (Tuberculosis, Hepatitis B Virus Infection, Hepatitis C Virus Infection) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/human-immunodeficiency-virus-hiv-market
    Explore at:
    Dataset updated
    Sep 23, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Sep 24, 2025
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 202345.66(USD Billion)
    MARKET SIZE 202446.91(USD Billion)
    MARKET SIZE 203258.2(USD Billion)
    SEGMENTS COVEREDTreatment Options ,Disease Stage ,Patient Population ,Mode of Transmission ,Comorbidities ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSGrowing prevalence of HIV Advancements in HIV treatment Government initiatives Increasing awareness
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDShionogi & Co. ,GlaxoSmithKline ,Eisai Co. ,Merck & Co. ,BristolMyers Squibb ,Boehringer Ingelheim ,Roche ,Pfizer ,Gilead Sciences ,Johnson & Johnson ,Novartis ,ViiV Healthcare ,AbbVie ,TAKEDA ,Astellas Pharma
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESGene therapyAdvancements in PrEP and PEP Increased focus on early diagnosis Expanded access to antiretroviral therapy Pointofcare diagnostics
    COMPOUND ANNUAL GROWTH RATE (CAGR) 2.73% (2025 - 2032)
  13. Sexually transmitted infections (STIs): annual data

    • gov.uk
    Updated Jun 10, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    UK Health Security Agency (2025). Sexually transmitted infections (STIs): annual data [Dataset]. https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables
    Explore at:
    Dataset updated
    Jun 10, 2025
    Dataset provided by
    GOV.UKhttp://gov.uk/
    Authors
    UK Health Security Agency
    Description

    The UK Health Security Agency (UKHSA) collects data on all sexually transmitted infection (STI) diagnoses made at sexual health services in England. This page includes information on trends in STI diagnoses, as well as the numbers and rates of diagnoses by demographic characteristics and UKHSA public health region.

    View the pre-release access lists for these statistics.

    Previous reports, data tables, slide sets, infographics, and pre-release access lists are available online:

    The STI quarterly surveillance reports of provisional data for diagnoses of syphilis, gonorrhoea and ceftriaxone-resistant gonorrhoea in England are also available online.

    Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the https://code.statisticsauthority.gov.uk/" class="govuk-link">Code of Practice for Statistics that all producers of Official Statistics should adhere to.

  14. w

    Global HIV Diagnostic Market Research Report: By Test Type (Antigen Tests,...

    • wiseguyreports.com
    Updated Dec 4, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global HIV Diagnostic Market Research Report: By Test Type (Antigen Tests, Antibody Tests, Nucleic Acid Tests), By Sample Type (Blood, Oral Fluid, Urine), By End User (Hospitals, Diagnostic Laboratories, Home Care Settings), By Technology (ELISA, Rapid Testing, PCR), By Distribution Channel (Direct Sales, Online Sales, Retail Pharmacies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/hiv-diagnostic-market
    Explore at:
    Dataset updated
    Dec 4, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20232.91(USD Billion)
    MARKET SIZE 20243.02(USD Billion)
    MARKET SIZE 20324.1(USD Billion)
    SEGMENTS COVEREDTest Type, Sample Type, End User, Technology, Distribution Channel, Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSIncreasing prevalence of HIV infections, Advances in diagnostic technologies, Government initiatives and funding, Growing awareness and education programs, Rise in point-of-care testing
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDRoche, Mylan, Beckman Coulter, Cepheid, Becton Dickinson, Quidel, PerkinElmer, Johnson and Johnson, Grifols, Hologic, Abbott, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, BioRad Laboratories
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESPoint-of-care testing innovations, Increased funding for HIV programs, Growing prevalence of HIV/AIDS, Enhanced data analytics for diagnosis, Rise in telemedicine for diagnostics
    COMPOUND ANNUAL GROWTH RATE (CAGR) 3.88% (2025 - 2032)
  15. T

    Greece - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated May 29, 2017
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). Greece - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/greece/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    excel, csv, xml, jsonAvailable download formats
    Dataset updated
    May 29, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    Greece
    Description

    Prevalence of HIV, total (% of population ages 15-49) in Greece was reported at 0.2 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Greece - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

  16. Total HIV/AIDS funding by the National Institutes for Health 2013-2025

    • statista.com
    • ai-chatbox.pro
    Updated Jul 9, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Total HIV/AIDS funding by the National Institutes for Health 2013-2025 [Dataset]. https://www.statista.com/statistics/716625/total-hiv-aids-funding-by-the-national-institutes-for-health/
    Explore at:
    Dataset updated
    Jul 9, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    HIV/AIDS funding by the NIH stood at around *** billion U.S. dollars in fiscal year 2023. This graph shows the total HIV/AIDS funding by the National Institutes for Health (NIH) from FY 2013 to FY 2023 and estimates for FY 2024 and FY 2025.

  17. w

    Global Hiv Antiretroviral Therapy Market Research Report: By Drug Class...

    • wiseguyreports.com
    Updated Jun 5, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Hiv Antiretroviral Therapy Market Research Report: By Drug Class (Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Integrase Inhibitors, Entry Inhibitors, Other Antiretrovirals), By Route of Administration (Oral, Parenteral, Topical), By Combination Therapies (Two-Drug Regimens, Three-Drug Regimens, Four-Drug Regimens, Five-Drug Regimens), By Patient Population (Newly Diagnosed Patients, Experienced Patients, Pediatric Patients, Pregnant Women, People with Comorbidities), By Treatment Duration (Short-Term Treatment (1 year), Intermediate-Term Treatment (1-5 years), Long-Term Treatment (>5 years)) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/hiv-antiretroviral-therapy-market
    Explore at:
    Dataset updated
    Jun 5, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Jan 6, 2024
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 202339.58(USD Billion)
    MARKET SIZE 202441.35(USD Billion)
    MARKET SIZE 203258.8(USD Billion)
    SEGMENTS COVEREDDrug Class ,Route of Administration ,Combination Regimens ,Patient Population ,Generic vs. Branded ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSIncrease in global HIVAIDS burden Development of advanced and innovative antiretroviral therapies Growing demand for affordable and accessible treatment options Emergence of generic and biosimilar drugs Stringent regulatory policies and reimbursement challenges
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILED- Gilead Sciences ,- ViiV Healthcare ,- Merck & Co ,- Janssen ,- Bristol-Myers Squibb ,- AbbVie
    MARKET FORECAST PERIOD2024 - 2032
    KEY MARKET OPPORTUNITIES1 Increasing prevalence of HIV 2 Development of new and effective drugs 3 Growing demand for generic drugs 4 Expansion of access to treatment 5 Rise in government funding
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.49% (2024 - 2032)
  18. Number of HIV cases Philippines 2012-2024

    • statista.com
    Updated May 8, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Number of HIV cases Philippines 2012-2024 [Dataset]. https://www.statista.com/statistics/701857/philippines-estimated-number-of-people-living-with-hiv/
    Explore at:
    Dataset updated
    May 8, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    Philippines
    Description

    The Philippines reported about ****** HIV cases, an increase from the previous year. The number of reported HIV cases has gradually increased since 2012, aside from a significant dip in 2020. The state of HIV As the monthly average number of people newly diagnosed with HIV increases, the risk it poses threatens the lives of Filipinos. HIV is a sexually transmitted infection that attacks the body’s immune system, with more males being diagnosed than females. In 2022, the majority of people newly diagnosed with HIV were those between the age of 25 and 34 years, followed by those aged 15 and 24. There is still no cure for HIV and without treatment, it could lead to other severe illnesses such as tuberculosis and cancers such as lymphoma and Kaposi’s sarcoma. However, HIV is now a manageable chronic illness that can be treated with proper medication. What are the leading causes of death in the Philippines? Between January and September 2024, preliminary figures have shown that ischaemic heart disease was the leading cause of death in the Philippines. The prevalence of heart diseases in the nation has been closely attributed to the Filipino diet, which was described as having a high fat, high cholesterol, and high sodium content. In addition, acute respiratory infections and hypertension also registered the highest morbidity rate among leading diseases in the country in 2021.

  19. w

    Global Lopinavir Market Research Report: By Route of Administration (Oral,...

    • wiseguyreports.com
    Updated Jul 26, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2025). Global Lopinavir Market Research Report: By Route of Administration (Oral, Intravenous, Inhalation, Topical), By Application (HIV/AIDS, COVID-19, Other Infections), By Dosage Strength (200 mg, 100 mg, 50 mg, 25 mg), By Combination Therapies (Lopinavir/Ritonavir, Lopinavir/Efavirenz, Lopinavir/Lamivudine), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/lopinavir-market
    Explore at:
    Dataset updated
    Jul 26, 2025
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Sep 24, 2025
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20237.08(USD Billion)
    MARKET SIZE 20247.54(USD Billion)
    MARKET SIZE 203212.5(USD Billion)
    SEGMENTS COVEREDRoute of Administration ,Application ,Dosage Strength ,Combination Therapies ,Distribution Channel ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSIncreasing prevalence of chronic diseases Rising geriatric population Technological advancements Growing awareness of lopinavir Increasing research and development activities
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDGlaxoSmithKline ,Sanofi ,Bristol Myers Squibb ,Pfizer ,Johnson & Johnson ,AbbVie ,Novartis ,Amgen ,Merck & Co ,Eli Lilly and Company ,Biogen ,Baxter International ,Gilead Sciences ,Roche ,Takeda Pharmaceutical Company
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESGrowing Prevalence of HIVAIDS Rising Demand in Developing Countries Technological Advancements Expanding Biosimilar Market Government Initiatives
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.52% (2025 - 2032)
  20. T

    Finland - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated May 31, 2017
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). Finland - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/finland/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    csv, xml, json, excelAvailable download formats
    Dataset updated
    May 31, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    Finland
    Description

    Prevalence of HIV, total (% of population ages 15-49) in Finland was reported at 0.1 % in 2018, according to the World Bank collection of development indicators, compiled from officially recognized sources. Finland - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
TRADING ECONOMICS (2017). Ghana - Prevalence Of HIV, Male (% Ages 15-24) [Dataset]. https://tradingeconomics.com/ghana/prevalence-of-hiv-male-percent-ages-15-24-wb-data.html

Ghana - Prevalence Of HIV, Male (% Ages 15-24)

Explore at:
csv, excel, json, xmlAvailable download formats
Dataset updated
May 29, 2017
Dataset authored and provided by
TRADING ECONOMICS
License

Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically

Time period covered
Jan 1, 1976 - Dec 31, 2025
Area covered
Ghana
Description

Prevalence of HIV, male (% ages 15-24) in Ghana was reported at 0.3 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Ghana - Prevalence of HIV, male (% ages 15-24) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

Search
Clear search
Close search
Google apps
Main menu